Introduction Among myoclonus-dystonia syndrome (MD) patients, psychiatric disorders
including depression, anxiety, alcohol dependence, obsessive-compulsive disorder (OCD) …

Abstract Objective Myoclonus‐dystonia (M‐D) is a hyperkinetic movement disorder, typically
alcohol‐responsive upper body myoclonus and dystonia. The majority of autosomal …

BACKGROUND: Neurological and psychiatric disorders show clinical overlap suggesting a
shared pathophysiological background. We evaluated myoclonus-dystonia, a monogenic …

Myoclonus-dystonia associated with epsilon-sarcoglycan gene (SGCE) is a rare disorder
characterized by myoclonus involving the upper body (neck, trunk, upper limbs) and …

Objective To perform phenotype and genotype characterization in myoclonus-dystonia
patients and to validate clinical rating tools. Method Two movement disorders experts rated …

Mutations of ε-sarcoglycan gene (SGCE) have been implicated in myoclonus-dystonia (MD),
a movement disorder. To determine the pathophysiology of MD, we produced Sgce …

Objective and importance: Myoclonus–dystonia syndrome (MDS, DYT11) is an inherited
disorder characterized by clinical and genetic heterogeneity. MDS is inherited in autosomal …

ABSTRACT Background Myoclonus‐Dystonia syndrome (M‐D) is an autosomal‐dominant
movement disorder related to SGCE gene pathogenic variants. Although there can be …

Introduction Myoclonus–dystonia (M–D) is a young onset movement disorder typically
involving myoclonus and dystonia of the upper body. A proportion of the cases are caused …

Background Myoclonus-dystonia (MD) due to a pathogenic variant of SGCE is an autosomal
dominant inherited movement disorder. Apart from motor symptoms, psychiatric disorders …